I have always thought and have periodically stated that RECOVERY RX could be the sleeping monster of all these products. The Actipatch (Recovery + Wave) on shelves with retail sales could be the familiar product to consumers, but Recovery RX, without such consumer exposure, IF adopted as standard procedure in surgical recovery would IMO blow away any and all other Bioelectronic product sales. AND I do not see why, once the ball gets rolling in the use of Recovery RX in surgeries, that this could not become the SOC (standard of care) in all surgeries. Why would any hospital, surgeon and/or MD NOT want to reduce their patients' pain and speed up the recovery of the surgical incision area. Many surgeries ONLY resulting pain, IS the incision.
How many surgeries are performed everyday world wide????
MONSTER!
(3)
(0)
BioElectronics Corporation (BIEL) Stock Research Links